Press Release
Do No Harm Calls on EEOC to Investigate Racially Discriminatory Internship Program
Share:
![](https://donoharmmedicine.org/wp-content/uploads/2022/11/DNH_ContentCards_PressRelease-1024x576.png)
RICHMOND, VA; July 18, 2024 – Do No Harm has requested that the United States Equal Employment Opportunity Commission (EEOC) investigate an internship program offered by the Alliance for Regenerative Medicine (ARM) for racial discrimination.
ARM, a medical organization that advocates for engineered cell therapies and genetic medicines, offered the GROW Internship Program, designed to provide undergraduate and graduate students with early-career paid opportunities in the regenerative medicine sector. However, the lucrative 12-week internship is open to only those students who “identify as Black/African American.”
“To flagrantly discriminate against applicants because of their race is reprehensible and unlawful — the Alliance for Regenerative Medicine (ARM) should be investigated and the program shut down,” said Do No Harm Board Chair Dr. Stanley Goldfarb. “The opportunity to engage in the sciences should be open to the best and the brightest and never be based on the color of one’s skin. The U.S. Equal Employment Opportunity Commission needs to open an investigation into ARM immediately.”
Do No Harm has called for the EEOC to open an investigation into ARM as the parameters they have set in place violate Title VII of the 1964 Civil Rights Act: “an unlawful employment practice for an employer to fail or refuse to hire or to discharge any individual, or otherwise discriminate against any individual with respect to his compensation, terms, conditions, or privileges of employment, because of such individual’s race.”
Click here to read the full complaint:
Do No Harm, established in April 2022, has rapidly gained recognition and made significant strides in its mission to safeguard healthcare from ideological threats. With more than 8,900 members, including doctors, nurses, physicians, and concerned citizens across all 50 states and in 14 countries, DNH has achieved more than 7,800 media hits in top-tier publications and garnered widespread attention through numerous broadcast news appearances.